Key facts
activeAcino Pharma GmbH
de
B1204_HRB704022
de
active
de
c/o Acino AG, Am Windfeld 35, 83714 Miesbach.
de
Company dossier
Acino Pharma GmbH
RISK SCORE31MEDIUM RISK
Connections
3 linksPeople with significant control
7 people| Name | Role | From | Source |
|---|---|---|---|
| Jürgen Doctor Betzing | Authorized representative | — | Germany registry |
| Marcel Thomas Werder | mit der Befugnis im Namen der Gesellschaft mit sich im eigen | — | Germany registry |
| Daniel Rupf | officer | — | Germany registry |
| Jürgen Doctor Betzing | officer | — | Germany registry |
| Max-Werner Doctor Scheiwe | officer | — | Germany registry |
| Peter Burema | officer | — | Germany registry |
| ⚠ Robert Schmid | officer | — | Germany registry |
Risk signals
3 matchedhigh
Business fragmentation
A director is shared across 50 companies — business-splitting (дробление) pattern
high
Phoenix predecessor
Shares a director with a failed, near-identically-named company (Acino Pharma GmbH · dissolved · name-sim 1.0) — phoenixing pattern (shed debts under a new company)
medium
Politically exposed person (PEP)
Robert Schmid (officer) matches PEP Robert Schmid — Member of the Swiss National Council, Switzerland. Apply enhanced due diligence.
Risk journey — why 31?
3 signals+16
Business fragmentation
+15
Phoenix predecessor
+0
Politically exposed person (PEP)
Composite risk score31/100